2017 |
R21 |
CA212500 |
RFA-CA-16-001 |
MOHS, AARON M. |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications |
NCE |
2017 |
R43 |
CA214386 |
PAR-13-327 |
PEYTAVI, REGIS |
BLUENOVO BIOSYSTEMS, INC. |
Detection of Methylation and Translocation Events by Novel Sequencing Technology |
Complete |
2017 |
R21 |
CA213247 |
RFA-CA-16-001 |
KRON, STEPHEN J. |
UNIVERSITY OF CHICAGO |
Tag-ChIP-MS for analysis of chromatin-level regulation of DNA repair |
Complete |
2017 |
R33 |
CA212697 |
RFA-CA-16-002 |
KLEIN, ALLON MOSHE |
HARVARD MEDICAL SCHOOL |
Droplet microfluidic technology for single cell cancer genomics |
Complete |
2017 |
R21 |
CA212718 |
RFA-CA-16-001 |
VAN DAM, ROBERT MICHAEL |
UNIVERSITY OF CALIFORNIA LOS ANGELES |
High-throughput radiochemistry platform for accelerated discovery and development of novel PET imaging agents for cancer |
Complete |
2017 |
R44 |
CA188154 |
PAR-13-327 |
PREMSRIRUT, PREM KHOVABUTR |
MIRIMUS, INC. |
Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research |
Complete |
2017 |
R21 |
CA214233 |
RFA-CA-16-001 |
SOELLNER, MATTHEW B |
UNIVERSITY OF MICHIGAN AT ANN ARBOR |
Exquisitely selective turn-on probes of kinase activation and localization |
NCE |
2017 |
R33 |
CA212806 |
RFA-CA-16-004 |
ZILBERBERG, JENNY |
HACKENSACK UNIVERSITY MEDICAL CENTER |
Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells |
NCE |
2018 |
R21 |
CA229044 |
RFA-CA-17-010 |
ABBOTT, KAREN L |
UNIV OF ARKANSAS FOR MED SCIS |
Novel platform linking cancer-specific glycosylation with cell signaling outcomes |
Active |
2018 |
R21 |
CA223715 |
RFA-CA-17-010 |
SHI, TUJIN |
BATTELLE PACIFIC NORTHWEST LABORATORIES |
An ultrasensitive targeted mass spectrometry system for proteomics analysis of single cells |
Active |
2018 |
R33 |
CA228979 |
RFA-CA-17-011 |
SCHRUM, ADAM G |
UNIVERSITY OF MISSOURI-COLUMBIA |
Multiplex matrix ELISA for T cell protein-interaction networks in cancer |
Active |
2018 |
R21 |
CA223901 |
RFA-CA-17-010 |
BRENT, ROGER |
FRED HUTCHINSON CANCER RESEARCH CENTER |
Precision controllers of mammalian gene expression |
Active |
2018 |
R21 |
CA223887 |
RFA-CA-17-010 |
SMITH, LLOYD M |
UNIVERSITY OF WISCONSIN-MADISON |
Novel NeuCode Tagging Reagents for Identification and Quantification of Intact Proteoforms in Cancer Tissues |
NCE |
2018 |
R33 |
CA229023 |
RFA-CA-17-011 |
TEWARI, MUNEESH (contact); WALTER, NILS G |
UNIVERSITY OF MICHIGAN AT ANN ARBOR |
Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations |
Active |
2018 |
R21 |
CA217735 |
RFA-CA-17-010 |
ENGLER, ADAM JEFFREY |
UNIVERSITY OF CALIFORNIA, SAN DIEGO |
Developing Adhesome Technology as a Physical Marker of Highly Metastatic Cells |
Complete |
2018 |
R21 |
CA214239 |
RFA-CA-17-010 |
VAN DEVENTER, JAMES ALLEN |
TUFTS UNIVERSITY MEDFORD |
Discovering hybrid inhibitors for tumor microenvironment disruption |
NCE |
2018 |
R21 |
CA229037 |
RFA-CA-17-012 |
GULLEY, MARGARET L |
UNIV OF NORTH CAROLINA CHAPEL HILL |
EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing |
Active |
2018 |
R21 |
CA223836 |
RFA-CA-17-010 |
FIELDS, RYAN C |
WASHINGTON UNIVERSITY |
Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment |
NCE |
2018 |
R33 |
CA223947 |
RFA-CA-17-011 |
BROWN, BRIAN D |
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
Pro-Codes: A novel vector and cell barcoding technology |
Active |
2018 |
R21 |
CA225507 |
RFA-CA-17-012 |
PAULOVICH, AMANDA G |
FRED HUTCHINSON CANCER RESEARCH CENTER |
Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome |
NCE |
2018 |
R21 |
CA229057 |
RFA-CA-17-010 |
FU, XIAO-AN |
UNIVERSITY OF LOUISVILLE |
A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath |
Active |
2018 |
R33 |
CA223581 |
RFA-CA-17-011 |
CHENG, JI-XIN |
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) |
Quantitative SRS Imaging of Cancer Metabolism at Single Cell Level |
Active |
2018 |
R21 |
CA229027 |
RFA-CA-17-012 |
SKARDAL, ALEKSANDER (contact); STROWD, ROY ERVIN |
WAKE FOREST UNIVERSITY HEALTH SCIENCES |
Predicting Tumor Heterogeneity Evolution After Therapy In Patient-Derived Ex Vivo Glioblastoma Organoids |
Complete |
2018 |
R21 |
CA223915 |
RFA-CA-17-010 |
KARGINOV, ANDREI V |
UNIVERSITY OF ILLINOIS AT CHICAGO |
Optogenetic tools for the dissection of oncogenic signaling mediated by kinases |
NCE |
2018 |
R33 |
CA223904 |
RFA-CA-17-011 |
CIMA, MICHAEL J |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors |
NCE |
2018 |
R33 |
CA217702 |
RFA-CA-17-013 |
BORGES, CHAD R |
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS |
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity |
Active |
2018 |
R21 |
CA214285 |
RFA-CA-17-010 |
MAILLOUX, ADAM WILLIAM |
H. LEE MOFFITT CANCER CTR & RES INST |
Autohistomagnetic Isolation of Tumor-reactive T-cells |
Complete |
2018 |
R33 |
CA225539 |
RFA-CA-17-011 |
JIANG, NING |
UNIVERSITY OF TEXAS, AUSTIN |
An integrated therapeutic T cell receptor screening platform for adoptive cell therapy in cancer |
Active |
2018 |
R33 |
CA214310 |
RFA-CA-17-013 |
INCE, TAN A. |
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE |
Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers |
Complete |
2018 |
R21 |
CA225474 |
RFA-CA-17-010 |
MEHTA, ANAND S |
MEDICAL UNIVERSITY OF SOUTH CAROLINA |
Glyco-typer: an antibody capture glycan imaging methodology |
NCE |
2018 |
R33 |
CA223908 |
RFA-CA-17-011 |
KONRY, TANIA TALI |
NORTHEASTERN UNIVERSITY |
Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform |
NCE |
2018 |
R43 |
CA236097 |
PAR-18-303 |
LIM, MARK |
AMBERGEN, INC |
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues |
Active |
2018 |
R21 |
CA223853 |
RFA-CA-17-010 |
ROBLES, FRANCISCO E |
GEORGIA INSTITUTE OF TECHNOLOGY |
Stimulated Raman scattering spectroscopic optical coherence tomography (SRS-SOCT) for label-free molecular imaging of brain tumor pathology |
NCE |
2018 |
R33 |
CA225494 |
RFA-CA-17-011 |
LIU, YANG |
UNIVERSITY OF PITTSBURGH AT PITTSBURGH |
High-throughput super-resolution imaging of chromatin structures at different epigenetic states |
NCE |
2018 |
R43 |
CA236101 |
PAR-18-303 |
LEE, LY JAMES |
NANOMATERIAL INNOVATION, LTD |
Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis |
Complete |
2018 |
R21 |
CA228997 |
RFA-CA-17-010 |
ROYZEN, MAKSIM |
STATE UNIVERSITY OF NEW YORK AT ALBANY |
Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies |
Active |
2018 |
R33 |
CA225863 |
RFA-CA-17-011 |
LU, JUN |
YALE UNIVERSITY |
CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer |
NCE |
2018 |
R43 |
CA236142 |
PAR-18-303 |
SCHOETTLE, LOUIS |
GEMNEO BIOSCIENCE, INC. |
Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes |
Complete |
2018 |
R21 |
CA228948 |
RFA-CA-17-010 |
SCHIBEL, ANNA |
ELECTRONIC BIOSCIENCES, INC. |
Microsatellite Sequencing to Enable Cancer Genotyping |
NCE |
2018 |
R33 |
CA222344 |
RFA-CA-17-011 |
SALIPANTE, STEPHEN J |
UNIVERSITY OF WASHINGTON |
Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods |
NCE |
2019 |
R43 |
CA236103 |
PAR-18-303 |
KHODAVERDIAN, VARANDT Y. |
NUPROBE USA, INC. |
Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing |
Complete |
2019 |
R21 |
CA240219 |
RFA-CA-18-004 |
ANDRES-MARTIN, LAURA |
NEW YORK STEM CELL FOUNDATION |
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections |
Active |
2019 |
R21 |
CA236561 |
RFA-CA-18-002 |
WEISSLEDER, RALPH |
MASSACHUSETTS GENERAL HOSPITAL |
Single Circulating Vesicle Analysis for Early Cancer Detection |
Active |
2019 |
R33 |
CA225549 |
RFA-CA-18-003 |
TAVANA, HOSSEIN |
UNIVERSITY OF AKRON |
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery |
Active |
2019 |
R43 |
CA236167 |
PAR-18-303 |
WARREN, CHRISTOPHER L |
PROTEOVISTA, LLC |
Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations |
NCE |
2019 |
R33 |
CA235326 |
RFA-CA-18-005 |
LEI, YUGUO |
UNIVERSITY OF NEBRASKA LINCOLN |
A Single Conical Tube Device for Precision CAR-T Cells Manufacturing |
Active |
2019 |
R21 |
CA236594 |
RFA-CA-18-002 |
GARBER, MANUEL |
UNIV OF MASSACHUSETTS MED SCH WORCESTER |
A modular; customizable sequencing system for simultaneous genotyping and transcript analysis in single cells |
Active |
2019 |
R33 |
CA229042 |
RFA-CA-18-003 |
SCHNECK, JONATHAN P |
JOHNS HOPKINS UNIVERSITY |
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells |
Active |
2019 |
R43 |
CA236177 |
PAR-18-303 |
KASOJI, SANDEEP |
TRIANGLE BIOTECHNOLOGY, INC. |
SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples |
Complete |
2019 |
R21 |
CA236640 |
RFA-CA-18-002 |
BHATNAGAR, PARIJAT |
SRI INTERNATIONAL |
T-cell Biofactories for targeting interstitial fluid pressure |
Active |